EVOK Logo.jpg
Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
May 16, 2024 16:02 ET | Evoke Pharma, Inc.
SOLANA BEACH, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with...
Palisade Bio_Logos(4.22)VSM.png
Palisade Bio to Present at Digestive Disease Week (DDW) 2024
February 15, 2024 08:35 ET | Palisade Bio, Inc.
Carlsbad, CA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on developing novel therapeutics for serious...
logo copy.jpg
Results of Pilot Study That Monitored Patients with Functional Dyspepsia, Gastroparesis and Vomiting Presented at Digestive Disease Week 2023
May 10, 2023 09:00 ET | G-Tech Medical
MOUNTAIN VIEW, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- G-Tech Medical today announced an oral presentation of an abstract entitled A Novel, Non-invasive, 6-day Wireless Motility Patch System...
logo copy.jpg
Interim Results of Study That Used Non-invasive Wireless Patches to Monitor Myoelectric Activity of Crohn’s Disease Patients in Flare and Remission
May 09, 2023 09:00 ET | G-Tech Medical
MOUNTAIN VIEW, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- G-Tech Medical, a developer of non-invasive diagnostic solutions for patients with gastrointestinal disorders, today announced presentation of...
Stella Diagnostics and Mayo Clinic to Present Data on the Utility of the STLA101 Test for Esophageal Cancer Staging at the 2022 AGA Digestive Disease Week Conference
May 11, 2022 08:30 ET | Stella Diagnostics, Inc
SALT LAKE CITY, May 11, 2022 (GLOBE NEWSWIRE) -- Stella Diagnostics, Inc. (OTC: SLDX), a molecular diagnostics-based organization optimizing patient management strategies for precancerous and...
Metacrine-Logo-R Transparent.png.png
Metacrine to Present New Preclinical Data on MET642 in Inflammatory Bowel Disease at Digestive Disease Week 2021 Virtual Meeting
May 19, 2021 08:05 ET | Metacrine, Inc.
SAN DIEGO, May 19, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal...
Interpace Diagnostics Reports Second Quarter 2019 Financial Results and Provides Business Update
August 13, 2019 08:15 ET | Interpace Diagnostics Group, Inc.
Second Quarter Revenue Grew 14% Over the Prior Year and 19% Year to Date Over the Prior Year Acquired Growing BioPharma Services Business Net Revenue Guidance Increased Conference Call and...
IDXG Logo.jpg
Interpace Diagnostics BarreGEN® Data to be Presented at Digestive Disease Week
May 09, 2019 06:55 ET | Interpace Diagnostics Group, Inc.
Company to Host Fellowship and Key Opinion Leader Programs PARSIPPANY, NJ, May 09, 2019 (GLOBE NEWSWIRE) --  Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) announced today that data from an...
Nash Pharmaceuticals to Present Data on Its Inflammatory Bowel Disease Research Program at The Digestive Disease Week Annual Conference
February 13, 2019 07:00 ET | Breathtec Biomedical Inc.
VANCOUVER, British Columbia, Feb. 13, 2019 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE: BTH) (CNSX: BTH) (FRANKFURT: BTI)...
PENTAX Medical Launches the SCOPEPILOT True 3D Endoscope Navigation System in Canada
March 03, 2017 07:30 ET | PENTAX Medical
MISSISSAUGA, Ontario, March 03, 2017 (GLOBE NEWSWIRE) -- PENTAX Medical, an industry leader in endoscopy imaging devices, has introduced SCOPEPILOT to the Canadian market and is showcasing this new...